alendronate has been researched along with SAPHO Syndrome in 3 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fioravanti, A | 1 |
| Cantarini, L | 1 |
| Burroni, L | 1 |
| Mazzei, MA | 1 |
| Volterrani, L | 1 |
| Galeazzi, M | 1 |
| Zhang, LL | 1 |
| Zhao, JX | 1 |
| Liu, XY | 1 |
| Witzig, M | 1 |
| Bützberger, S | 1 |
| Caravatti, M | 1 |
| Furrer, J | 1 |
| Schulthess, G | 1 |
3 other studies available for alendronate and SAPHO Syndrome
| Article | Year |
|---|---|
Efficacy of alendronate in the treatment of the SAPHO syndrome.
Topics: Acquired Hyperostosis Syndrome; Adult; Alendronate; Bone Density Conservation Agents; Female; Humans | 2008 |
Successful treatment of SAPHO syndrome with severe spinal disorder using entercept: a case study.
Topics: Acquired Hyperostosis Syndrome; Alendronate; Antirheumatic Agents; Bone Density Conservation Agents; | 2012 |
[Backache and palmar eczema (SAPHO syndrome)].
Topics: Acquired Hyperostosis Syndrome; Alendronate; Anti-Inflammatory Agents, Non-Steroidal; Back Pain; Dia | 2003 |